LeonaBio shareholders approve 2026 equity plan, 4x authorized share increase, and Sermonix warrant exercise

LeonaBio, Inc.

Authorized common shares increased from 90M to 400M; total capital stock from 190M to 500M.
2026 Equity Incentive Plan approved: up to 5.7M shares initially, plus potential additions from lapsed 2020 Plan awards.
Stockholders approved issuance of 5,502,402 shares upon exercise of Sermonix pre-funded warrant.
Issuance to Sermonix and Perceptive Advisors exceeding 19.99% beneficial ownership also approved.
2026 Plan includes annual evergreen increase equal to the lesser of 5% of outstanding shares or Board-determined amount.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.